The 29th Annual International Congress on Hematologic Malignancies 2025 is dedicated to the clinician application of the wealth of emerging data in treating hematologic malignancies with a focus on leukemias, lymphomas and myeloma.
The 29th Annual International Congress on Hematologic Malignancies 2025 covers topics such as:
The 29th Annual International Congress on Hematologic Malignancies 2025 brings together oncologists and other healthcare professionals.